Neomycin may treat viral respiratory infections, says study
HQ Team April 27, 2024: Viral infections are commonly treated with antivirals. The recent Covid-19 pandemic saw the SARS CoV-2 virus being treated.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 27, 2024: Viral infections are commonly treated with antivirals. The recent Covid-19 pandemic saw the SARS CoV-2 virus being treated.
HQ Team April 19, 2024: The WHO, health experts and agencies have agreed on the terminology used to describe the spread of a.
HQ Team March 27, 2024: Humans transmit more viruses in domestic and wild animals than the other way around, scientists found after analyzing.
HQ Team March 21, 2024: A panel consisting of Nobel laureates, former presidents and prime ministers have urged global negotiators of WHO member.
HQ Team March 20, 2024: The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study.
HQ Team March 13, 2024: Lysolipid, a byproduct of the human immune response to viruses and bacteria, may be behind lung instability caused.
HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.
HQ Team March 2, 2024: The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients.
HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave.
HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared.